Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
55.62
+2.06 (3.85%)
At close: Jun 13, 2025, 4:00 PM
54.65
-0.97 (-1.74%)
After-hours: Jun 13, 2025, 7:12 PM EDT
Akero Therapeutics Employees
Akero Therapeutics had 63 employees as of December 31, 2024. The number of employees increased by 7 or 12.50% compared to the previous year.
Employees
63
Change (1Y)
7
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$4,276,841
Market Cap
4.43B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AKRO News
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation - Accesswire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Reach Out - Accesswire
- 11 days ago - Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 16 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation - Accesswire
- 17 days ago - Akero Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Investors to Learn More About the Investigation - Accesswire